Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block

Annals of the Rheumatic Diseases

Volumn 62, Issue 10, 2003, Pages 1010-1012

  Costedoat Chalumeau, N ^a   Amoura, Z ^a   Le Thi Hong, D ^a   Wechsler, B ^a   Vauthier, D ^a   Ghillani, P ^a   Papo, T ^a   Fain, O ^a   Musset, L ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETAMETHASONE; DEXAMETHASONE; PREDNISONE;

ADRENAL CORTEX ATROPHY; ADRENAL INSUFFICIENCY; ADULT; ANAMNESIS; ARTICLE; BIOSAFETY; BLOOD PLACENTA BARRIER; CONGENITAL HEART BLOCK; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG USE; FEMALE; FETUS; FETUS DEVELOPMENT; FLUORINATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPLASIA; INTRAUTERINE GROWTH RETARDATION; MOTHER; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; STEROID THERAPY; STILLBIRTH; UNIVERSITY HOSPITAL;

ADRENAL INSUFFICIENCY; ANTIBODIES, ANTINUCLEAR; DEXAMETHASONE; FEMALE; FETAL GROWTH RETARDATION; HEART BLOCK; HUMANS; INFANT, NEWBORN; PREDNISOLONE; PREGNANCY; PREGNANCY, HIGH-RISK; RETROSPECTIVE STUDIES; STEROIDS, FLUORINATED; TREATMENT FAILURE;

EID: 0141539337     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.10.1010     Document Type: Article

References (19)

1. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
2. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
3. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999;42:2335-45.
4. Buyon JP, Copel JA, Friedman DM. Anti-SSA/Ro and -SSB/La antibodies. In: Miller H, ed. Decision making in obstetrics. In press.
5. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K. Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 1999;93:952-7.
6. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.
7. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol 1993;20:1204-7.
8. Brucato A, Buyon JP, Horsfall AC, Lee LA, Reichlin M. Fourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB System. Clin Exp Rheumatol 1999;17:130-6.
9. Bloom SL, Sheffield JS, McIntire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001;97:485-90.
10. Dodic M, Samuel C, Moritz K, Wintour EM, Morgan J, Grigg L, et al. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res 2001;89:623-9.
11. Zecca E, Papacci P, Maggio L, Gallini F, Elia S, De Rosa G, et al. Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol 2001;41:1075-81.
12. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and brood pressure at 14 years of age in preterm children. Clin Sci (Colch) 2000;98:137-42.
13. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 1990;53:157-67.
14. Miller WL. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. J Urol 1999;162:537-40.
15. Lajic S, Wedell A, Bui TH, Ritzen EM, Holst M. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872-80.
16. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001;107:217-21.
17. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001;1:1.
18. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.
19. Baud O, Laudenbach V, Evrard P, Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res 2001;50:706-11.